Reiko Horikawa

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

The Journal of clinical endocrinology and metabolism

European journal of endocrinology

Drug design, development and therapy

Journal of the Endocrine Society

National Center For Child Health and Development

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Center For Child Health and Development Mar 01 2002

Japan

Director :: Division of Endocrinology and Metabolism

Publications

Bradley S Miller, Joanne C Blair, Reiko Horikawa, Agnès Linglart, Kevin C J Yuen
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan. Drug design, development and therapy 18 (2024)
Anders Juul, Philippe F Backeljauw, Michael Højby Rasmussen, Jan Frystyk, Masanobu Kawai, Rasmus Juul Kildemoes, Anders Krogh Lemminger, Agnès Linglart, Nehama Zuckerman Levin, Reiko Horikawa
Somapacitan in Children Born SGA: 52-week Efficacy, Safety, and IGF-I Response Results from the Phase 2 REAL5 Study. The Journal of clinical endocrinology and metabolism (2024)
Bradley S Miller, Joanne C Blair, Reiko Horikawa, Agnès Linglart, Kevin C J Yuen
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan. Drug design, development and therapy 18 (2024)
Bradley S Miller, Joanne C Blair, Reiko Horikawa, Agnès Linglart, Kevin C J Yuen
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan. Drug design, development and therapy 18 (2024)
Bradley S Miller, Joanne C Blair, Reiko Horikawa, Agnès Linglart, Kevin C J Yuen
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan. Drug design, development and therapy 18 (2024)
Akiko Sankoda, Naoko Arata, Shiori Sato, Nagayoshi Umehara, Naho Morisaki, Yushi Ito, Haruhiko Sago, Yuichiro Yano, Reiko Horikawa
Association of Isolated Hypothyroxinemia and Subclinical Hypothyroidism With Birthweight: A Cohort Study in Japan. Journal of the Endocrine Society 7 (5) (2023)
Bradley S Miller, Joanne C Blair, Michael Højby Rasmussen, Aristides Maniatis, Jun Mori, Volker Böttcher, Ho-Seong Kim, Rikke Beck Bang, Michel Polak, Reiko Horikawa
Effective GH Replacement with Somapacitan in Children with GHD: REAL4 2-year Results and after Switch from Daily GH. The Journal of clinical endocrinology and metabolism (2023)
Lars Savendahl, Tadej Battelino, Michael Højby Rasmussen, Meryl Brod, Sebastian Röhrich, Paul Saenger, Reiko Horikawa
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety and Treatment/Disease Burden Results from REAL 3. The Journal of clinical endocrinology and metabolism (2023)
Anders Juul, Philippe Backeljauw, Michael Højby, Masanobu Kawai, Rasmus Juul Kildemoes, Agnès Linglart, Nehama Zuckerman-Levin, Reiko Horikawa
Somapacitan in children born small for gestational age: a multi-centre, open-label, controlled phase 2 study. European journal of endocrinology 188 (1) (2023)
Akiko Sankoda, Naoko Arata, Shiori Sato, Nagayoshi Umehara, Naho Morisaki, Yushi Ito, Haruhiko Sago, Yuichiro Yano, Reiko Horikawa
Association of Isolated Hypothyroxinemia and Subclinical Hypothyroidism With Birthweight: A Cohort Study in Japan. Journal of the Endocrine Society 7 (5) (2023)
Anders Juul, Philippe Backeljauw, Michael Højby, Masanobu Kawai, Rasmus Juul Kildemoes, Agnès Linglart, Nehama Zuckerman-Levin, Reiko Horikawa
Somapacitan in children born small for gestational age: a multi-centre, open-label, controlled phase 2 study. European journal of endocrinology 188 (1) (2023)
Anita C S Hokken-Koelega, Manouk van der Steen, Margaret C S Boguszewski, Stefano Cianfarani, Jovanna Dahlgren, Reiko Horikawa, Veronica Mericq, Robert Rapaport, Abdullah Alherbish, Debora Braslavsky, Evangelia Charmandari, Steven D Chernausek, Wayne S Cutfield, Andrew Dauber, Asma Deeb, Wesley J Goedegebuure, Paul L Hofman, Elvira Isganatis, Alexander A Jorge, Christina Kanaka-Gantenbein, Kenichi Kashimada, Vaman Khadilkar, Xiao-Ping Luo, Sarah Mathai, Yuya Nakano, Mabel Yau
International Consensus Guideline on Small for Gestational Age (SGA): Etiology and Management from Infancy to Early Adulthood. Endocrine reviews (2023)
Anders Juul, Philippe Backeljauw, Michael Højby, Masanobu Kawai, Rasmus Juul Kildemoes, Agnès Linglart, Nehama Zuckerman-Levin, Reiko Horikawa
Somapacitan in children born small for gestational age: a multi-centre, open-label, controlled phase 2 study. European journal of endocrinology 188 (1) (2023)
Mohamad Maghnie, Michael B. Ranke, Mitchell E Geffner, Elpis-Athina Vlachopapadopoulou, Lourdes Ibáñez, Martin Carlsson, Wayne S Cutfield, Raoul Rooman, Roy Gomez, Michael P Wajnrajch, Agnès Linglart, Renata Stawerska, Peter E Clayton, Feyza Darendelıler, Anita C S Hokken-Koelega, Reiko Horikawa, Toshiaki Tanaka, Helmuth-Günther Dörr, Kerstin G Albertsson-Wikland, Michel Polak, Adda Grimberg
Response to Letter to the Editor from Virú-Loza and Chávez-Nomberto: "Safety and efficacy of pediatric growth hormone therapy: Results from the full KIGS cohort". The Journal of clinical endocrinology and metabolism (2023)
Mohamad Maghnie, Michael B. Ranke, Mitchell E Geffner, Elpis-Athina Vlachopapadopoulou, Lourdes Ibáñez, Martin Carlsson, Wayne S Cutfield, Raoul Rooman, Roy Gomez, Michael P Wajnrajch, Agnès Linglart, Renata Stawerska, Peter E Clayton, Feyza Darendelıler, Anita C S Hokken-Koelega, Reiko Horikawa, Toshiaki Tanaka, Helmuth-Günther Dörr, Kerstin G Albertsson-Wikland, Michel Polak, Adda Grimberg
Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort. The Journal of clinical endocrinology and metabolism 107 (12) (2022)
Bradley S Miller, Joanne C Blair, Michael Højby Rasmussen, Aristides Maniatis, Rasmus Juul Kildemoes, Jun Mori, Michel Polak, Rikke Beck Bang, Volker Böttcher, Stefano Stagi, Reiko Horikawa
Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial. The Journal of clinical endocrinology and metabolism 107 (12) (2022)
Sayaka Aoki, Keiji Hashimoto, Kohei Ogawa, Reiko Horikawa, Haruhiko Sago
Developmental outcomes in Japanese preschool-age children conceived through assisted reproductive technology. The journal of obstetrics and gynaecology research 48 (11) (2022)
Margaret C S Boguszewski, Cesar L Boguszewski, Wassim Chemaitilly, Laurie E Cohen, Judith Gebauer, Claire Higham, Andrew R Hoffman, Michel Polak, Kevin C J Yuen, Nathalie Alos, Zoltan Antal, Martin Bidlingmaier, Beverley M K Biller, George Brabant, Catherine S Y Choong, Stefano Cianfarani, Peter Ellis Clayton, Regis Coutant, Adriane A Cardoso-Demartini, Alberto Fernandez, Adda Grimberg, Kolbeinn Guðmundsson, Jaime Guevara-Aguirre, Ken K Y Ho, Reiko Horikawa, Andrea M Isidori, Jens Otto Lunde Jørgensen, Peter Kamenickỷ, Niki Karavitaki, John J Kopchick, Maya Lodish, Xiaoping Luo, Ann I McCormack, Lillian Meacham, Shlomo Melmed, Sogol Mostoufi Moab, Hermann L Müller, Sebastian J C M M Neggers, Manoel H Aguiar Oliveira, Keiichi Ozono, Patricia A Pennisi, Vera Popovic, Sally Radovick, Lars Savendahl, Philippe A Touraine, Hanneke M van Santen, Gudmundur Johannsson
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement. European journal of endocrinology 186 (6) (2022)
Emiko Ando, Naho Morisaki, Keiko Asakura, Satoshi Sasaki, Takeo Fujiwara, Reiko Horikawa
Serum 25-hydroxyvitamin D levels showed strong seasonality but lacked association with vitamin D intake in 3-year-old Japanese children. The British journal of nutrition 120 (9) (2018)

Reiko Horikawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Reiko Horikawa